| Financial Year |
March 31 2023 |
| Monetary Funds |
423,841,458.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
20,437,996.28 |
| Advances to Suppliers |
39,307,029.62 |
| Other Receivables |
264,440,394.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,571,199,701.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
216,131,792.15 |
| Total Current Assets |
3,535,358,371.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
808,742,247.73 |
| Long-term Equity Investment |
3,247,307,550.14 |
| Investment Properties |
229,938,274.69 |
| Fixed Assetes |
3,197,214,936.47 |
| Under-construction Projects |
186,147,117.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
293,039,771.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,112,238,823.39 |
| Deferred Income Tax Assets |
39,463,597.80 |
| Other Non-Current Assets |
562,427,654.70 |
| Sub-Total of Non-Current Assets |
11,363,417,180.34 |
| Total Assets |
14,898,775,552.21 |
| Short-Term Loans |
2,355,020,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
838,664,787.39 |
| Accounts Received In Advance |
23,600,790.58 |
| Employee Compensation Payable |
9,829,569.30 |
| Taxes Payable |
13,862,131.14 |
| Interest Payable |
21,205,749.65 |
| Dividend Payable |
-- |
| Other payables |
344,923,239.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
420,087,838.40 |
| Other Current Liabilities |
68,815,014.96 |
| Sub-Total of Current Liabilities |
4,645,981,822.26 |
| Long-term Loans |
769,700,000.00 |
| Bonds Payable |
939,619,972.40 |
| Long-Term Accounts Payable |
271,166,022.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,346,912,768.06 |
| Total Liabilities |
7,992,894,590.32 |
| Paid-In Capital(Or Share Stock) |
1,394,172,800.00 |
| Capital Surplus |
721,570,277.11 |
| Surplus Reserve |
697,086,400.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,855,367,727.99 |
| Minority Stockholder's Interest |
232,227,949.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,673,653,012.69 |
| Owner's Equity（Stockholder's Equity） |
6,905,880,961.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,898,775,552.21 |
